Sound Pharmaceuticals, Inc
- | Biotech or pharma, therapeutic R&D
Pioneering neurotology company with multiple Phase 2/3 programs in hearing loss, ototoxicity and tinnitus. Expanding into neuropsychiatric and CF indications. Phase 3 in Meniere's disease begins enrollment in June at 20+ US sites and is Fast Tracked
Address
SeattleWA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}